PD51: Kidney Cancer: Basic Research & Pathophysiology II
303A
Poster and Podium Sessions
Oncology: Adrenal/Kidney
Information
Continuing Medical Education
CME
Sunday, May 5
PD51-01: Plasma tsRNAs as novel diagnostic biomarkers for renal cell carcinoma
Sunday, May 5, 2024 3:30 PM to 3:40 PM
303A
PD51-02: Integrative Molecular Profiling of Renal Cell Carcinoma Native Tissue and Patient Derived Organoids Identifies Predictive Markers of Drug Response
Sunday, May 5, 2024 3:40 PM to 3:50 PM
303A
PD51-03: Connexin-26 expression is associated with disease outcomes in clear cell renal cell carcinoma and may be a source of intratumoral adenosine
Sunday, May 5, 2024 3:50 PM to 4:00 PM
303A
PD51-04: Identification of Novel HIF Independent Oncogenic Targets in Clear Cell Renal Cell Carcinoma
Sunday, May 5, 2024 4:00 PM to 4:10 PM
303A
PD51-05: Allele-specific DNA methylation affecting the STEAP3 gene in renal cell carcinomas
Sunday, May 5, 2024 4:10 PM to 4:20 PM
303A
PD51-06: Targeting glutamine addiction to induce ferroptosis with potent drug combination therapy for renal cell carcinoma
Sunday, May 5, 2024 4:20 PM to 4:30 PM
303A
PD51-07: Regulation of glutamine metabolism resensitizes TKI-resistant renal cancer cells to TKIs
Sunday, May 5, 2024 4:30 PM to 4:40 PM
303A
PD51-08: SREBP1 Induces Resistance to HIF-2α antagonist in Clear Cell Renal Cell Carcinoma
Sunday, May 5, 2024 4:40 PM to 4:50 PM
303A
PD51-10: Estrogen receptor signals promote autophagy and M2 macrophage polarization in the TKI-resistant RCC
Sunday, May 5, 2024 4:50 PM to 5:00 PM
303A
PD51-11: Icarside II and sunitinib cooperatively induce apoptosis of renal cell carcinoma cells via activating the ATF4/Noxa axis and inhibiting the PI3K/Akt pathway
Sunday, May 5, 2024 5:00 PM to 5:10 PM
303A
PD51-12: Comprehensive Immunogenomic Evaluation of Patients Undergoing Consolidative Cytoreductive Nephrectomy in Metastatic Renal Cell Carcinoma Patients Treated with Immune Checkpoint Blockade
Sunday, May 5, 2024 5:10 PM to 5:20 PM
303A